Freenome partners with Biognosys to develop cancer screen

Freenome Inc. (South San Francisco, Calif.) partnered non-exclusively with Biognosys AG (Schlieren, Switzerland) to enhance Freenome’s AI-based genomics platform for detecting cell-free biomarkers. Biognosys will use its parallel mass spectrometry platform to build plasma proteome datasets for use with Freenome's AI platform to develop a cancer screen...